Page de couverture de 52. Tamoxifen vs aromatase inhibitor to prevent recurrence of my breast cancer

52. Tamoxifen vs aromatase inhibitor to prevent recurrence of my breast cancer

52. Tamoxifen vs aromatase inhibitor to prevent recurrence of my breast cancer

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

Because of breast cancer, fear of cancer recurrence is a permanent part of my life. I continue taking tamoxifen to reduce my risk of the cancer coming back. In this episode I share my thoughts on the good quality of life I have while taking tamoxifen. I value my strong body and theimited side-effects I have now. I also value a life with the lowest possible risk of breast cancer recurrence. I look forward to discussing what it might mean to switch to an aromatase inhibitor, in terms of further lowering the risk of recurrence and potentially experiencing more serious side-effects, with my oncologist

On more than one occasion, the oncologist has brought up endocrine therapy and the possibility of switching from tamoxifen to an aromatase inhibitor “in the future”. Even my breast surgeon provided a quick plug for the lower risk of recurrence associated with taking aromatase inhibitors, compared to tamoxifen, without highlighting any of the aromatase inhibitor side-effects. Determining what might be the best endocrine therapy for me to prevent recurrence is not going to be easy. So far, neither doctor has done a deep dive into the different side-effects among the two drugs or what a change might do to overall health and quality of life.

Thank you for listening to my story!

If you’d like to be the first to receive updates and exclusive content from the upcoming Breast Cancer Life newsletter, please email me at connect@breastcancerlife.org. I’d love to have you on the list!

LET'S CONNECT:

connect@breastcancerlife.org

Follow us on Pinterest

Ce que les auditeurs disent de 52. Tamoxifen vs aromatase inhibitor to prevent recurrence of my breast cancer

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.